MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 2 | 0.0 |
Humans | 41 | 0.0 |
Mutation | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Adult | 7 | 0.0 |
Aged | 6 | 0.0 |
Comparative Study | 4 | 0.0 |
Female | 14 | 0.0 |
*Genes, ras | 10 | 4.0 |
Male | 16 | 0.0 |
Middle Aged | 7 | 0.0 |
*Mutation | 2 | 0.0 |
*Alleles | 2 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Genotype | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Risk Factors | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
ras Proteins/genetics/*physiology | 2 | 25.0 |
Animals | 14 | 0.0 |
Cell Division | 3 | 0.0 |
*Cell Transformation, Neoplastic | 3 | 0.0 |
Cells, Cultured | 4 | 0.0 |
GTP-Binding Proteins/metabolism | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Mice | 10 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Rats | 2 | 0.0 |
Transfection | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Gene Expression | 2 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Neoplasms/*genetics | 2 | 0.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Proto-Oncogene Proteins B-raf | 2 | 2.0 |
Child | 6 | 0.0 |
Child, Preschool | 4 | 0.0 |
Infant | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Proto-Oncogene Protein p21(ras)/genetics | 2 | 13.0 |
X Chromosome | 2 | 0.0 |
Genetic Markers | 4 | 0.0 |
Karyotyping | 3 | 0.0 |
Alleles | 5 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Mice, Nude | 3 | 0.0 |
Neoplasm Transplantation | 3 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
*Chromosomes, Human, Pair 11 | 12 | 1.0 |
Lung Neoplasms/*genetics | 2 | 0.0 |
Adolescent | 6 | 0.0 |
Genes, ras/*genetics | 5 | 5.0 |
Heterozygote Detection | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Proto-Oncogene Protein p21(ras)/*genetics | 3 | 17.0 |
Base Sequence | 5 | 0.0 |
Polymorphism, Restriction Fragment Length | 6 | 0.0 |
Bladder Neoplasms/*genetics/pathology | 2 | 5.0 |
Blotting, Southern | 4 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
DNA/analysis | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Skin Neoplasms/genetics | 2 | 6.0 |
Hybrid Cells | 2 | 0.0 |
Neoplasms, Germ Cell and Embryonal/*genetics | 2 | 16.0 |
Globins/genetics | 2 | 1.0 |
*Linkage (Genetics) | 6 | 0.0 |
Pedigree | 4 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Chromosome Mapping | 9 | 0.0 |
Genes, Recessive | 2 | 0.0 |
Tyrosine 3-Monooxygenase/*genetics | 2 | 1.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Proto-Oncogene Proteins c-myc | 2 | 5.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
DNA Restriction Enzymes | 2 | 0.0 |
*Genes, Structural | 3 | 0.0 |
Globins/*genetics | 2 | 1.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
DNA Methylation | 2 | 0.0 |
